Insider · CIK 0002034505
Jerome Charles Bressi
officer
Files at FATE (FATE THERAPEUTICS INC). First filing Jan 13, 2025, latest Jan 13, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $9,269 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 30Weak | sell 3 | FATE FATE THERAPEUTICS INC | $9,269 | 5,980 | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | FATE FATE THERAPEUTICS INC | AGrant or award Common Stock | +65,000 | $0.00 | $0 | 335,203 | Jan 16, 2025 |
| Jan 15, 2025 | FATE FATE THERAPEUTICS INC | AGrant or award Stock Option (Right to Buy)derivative | +250,000 | $0.00 | $0 | 250,000 | Jan 16, 2025 |
| Jan 10, 2025 | FATE FATE THERAPEUTICS INC | SOpen-market sale Common Stock | -5,980 | $1.55 | $9,269 | 270,203 | Jan 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.